Physician profile
Barbara Croft
NPI 1669429791
$383.51
in general payments reported to CMS, 2019-2025
14 companies · $78.06 in 2025
The $78.06 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $31.40 · 2025: $78.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $78.06 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Therapeuticsmd, INC. | $53.79 | 2019 | |
| Abbvie INC. | $48.87 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.20 | 2019 | |
| Vertical Pharmaceuticals, LLC | $30.89 | 2019 | |
| Pfizer INC. | $25.61 | 2019-2020 | |
| Hologic Sales and Service, LLC | $17.33 | 2020 | |
| Amag Pharmaceuticals, INC. | $16.37 | 2019 | |
| Astellas Pharma US INC | $16.21 | 2019 | |
| Merck Sharp & Dohme LLC | $15.34 | 2019 | |
| Ascend Therapeutics US, LLC | $13.06 | 2019 | |
| Becton, Dickinson and Company | $12.81 | 2019 | |
| Minerva Surgical, INC | $11.53 | 2019 | |
| Meditrina | $8.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Croft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.